Pioglitazone inhibits mRNA and protein levels of hepatic Fetuin-A, and oral administration of pioglitazone in mice partially ameliorates insulin resistance with decreases on hepatic fetuin-A expression [286]. Here, AHSG is linked to Insulin resistance.